PT103003A - Set of medicinal metal enzyme high capacity inhibitors comprises succinic and iminodiacetic acids giving high zinc and nickel ion complexing capacity - Google Patents

Set of medicinal metal enzyme high capacity inhibitors comprises succinic and iminodiacetic acids giving high zinc and nickel ion complexing capacity

Info

Publication number
PT103003A
PT103003A PT103003A PT103003A PT103003A PT 103003 A PT103003 A PT 103003A PT 103003 A PT103003 A PT 103003A PT 103003 A PT103003 A PT 103003A PT 103003 A PT103003 A PT 103003A
Authority
PT
Portugal
Prior art keywords
capacity
ion complexing
nickel ion
inhibitors comprises
metal enzyme
Prior art date
Application number
PT103003A
Other languages
Portuguese (pt)
Inventor
Maria Amelia Loureiro D Santos
Sergio Manuel Marques
Marco Antonio Dias De Sous Gil
Matteo Tegoni
Silvia Chaves
Original Assignee
Inst Superior Tecnico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Superior Tecnico filed Critical Inst Superior Tecnico
Priority to PT103003A priority Critical patent/PT103003A/en
Publication of PT103003A publication Critical patent/PT103003A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Set of medicinal metal enzyme high capacity inhibitors comprises succinic and iminodiacetic acids containing at least one hydroxamate group and functional groups or moelcular residues. The Zn (II) and Ni (II) ion complexing capacity is high, for inhibiting metalloproteinases (matrices and bacteria pharmacology).
PT103003A 2003-08-04 2003-08-04 Set of medicinal metal enzyme high capacity inhibitors comprises succinic and iminodiacetic acids giving high zinc and nickel ion complexing capacity PT103003A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PT103003A PT103003A (en) 2003-08-04 2003-08-04 Set of medicinal metal enzyme high capacity inhibitors comprises succinic and iminodiacetic acids giving high zinc and nickel ion complexing capacity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT103003A PT103003A (en) 2003-08-04 2003-08-04 Set of medicinal metal enzyme high capacity inhibitors comprises succinic and iminodiacetic acids giving high zinc and nickel ion complexing capacity

Publications (1)

Publication Number Publication Date
PT103003A true PT103003A (en) 2005-02-28

Family

ID=34836875

Family Applications (1)

Application Number Title Priority Date Filing Date
PT103003A PT103003A (en) 2003-08-04 2003-08-04 Set of medicinal metal enzyme high capacity inhibitors comprises succinic and iminodiacetic acids giving high zinc and nickel ion complexing capacity

Country Status (1)

Country Link
PT (1) PT103003A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9700599B2 (en) 2012-11-13 2017-07-11 Adocia Rapid-acting insulin formulation comprising a substituted anionic compound
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
US10525133B2 (en) 2014-05-14 2020-01-07 Adocia Aqueous composition comprising at least one protein and one solubilizing agent, preparation thereof and uses thereof
US10792335B2 (en) 2015-11-16 2020-10-06 Adocia Rapid-acting insulin composition comprising a substituted citrate

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9700599B2 (en) 2012-11-13 2017-07-11 Adocia Rapid-acting insulin formulation comprising a substituted anionic compound
US10583175B2 (en) 2012-11-13 2020-03-10 Adocia Rapid-acting insulin formulation comprising a substituted anionic compound
US10646551B2 (en) 2012-11-13 2020-05-12 Adocia Rapid-acting insulin formulation comprising a substituted anionic compound
US10881716B2 (en) 2012-11-13 2021-01-05 Adocia Rapid-acting insulin formulation comprising a substituted anionic compound
US11324808B2 (en) 2012-11-13 2022-05-10 Adocia Rapid-acting insulin formulation comprising a substituted anionic compound
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
US10525133B2 (en) 2014-05-14 2020-01-07 Adocia Aqueous composition comprising at least one protein and one solubilizing agent, preparation thereof and uses thereof
US10792335B2 (en) 2015-11-16 2020-10-06 Adocia Rapid-acting insulin composition comprising a substituted citrate

Similar Documents

Publication Publication Date Title
EP1983000A3 (en) Method for the treatment of multiple sclerosis by inhibiting IL-17 activity
AU2964295A (en) Inhibitors of leukocyte adhesion
WO2006040357A3 (en) Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
AU2001278157A1 (en) Liquid composition
CA2397124A1 (en) Method for disinfecting a dense fluid medium in a dense medium plasma reactor
IL109177A0 (en) Inhibitor of stem cell proliferation and uses thereof
WO2004043374A3 (en) Methods and compositions for treating cancer using proteasome inhibitors
MX2009006227A (en) Aspartyl protease inhibitors containing a tricyclic ring system.
IN2006KO01346A (en)
MY117948A (en) Nitride oxide synthase inhibitors.
HK1156515A1 (en) Pharmaceutical compositions and methods for accelerating wound healing
AU2002363250A1 (en) Pyrazole-amides and-sulfonamides
WO2004047879A3 (en) Antimicrobial lenses, processes to prepare them and methods of their use
SI1805211T1 (en) Purification of glycopeptides
HK1108701A1 (en) Inhibitor of stem cell proliferation and uses thereof
EP0813544A4 (en)
AU2003238386A1 (en) Electrode for gas evolution and method for its production
AU2003223913A1 (en) Agents for treating less thanigreater thanflaviviridaeless than/igreater than infections
WO2004087073A3 (en) Treatment of demyelinating conditions
PT103003A (en) Set of medicinal metal enzyme high capacity inhibitors comprises succinic and iminodiacetic acids giving high zinc and nickel ion complexing capacity
TW200608893A (en) An iron sequestering antimicrobial composition
IL165259A (en) Compounds useful in the treatment of anthrax and inhibiting lethal factor
UA91057C2 (en) An oligonucleotide or its functional homologue, a composition comprising the same and a method for treating b cell neoplasm
WO2004084799A3 (en) Pharmaceutical compositions for inhibiting metal ion dependent enzymatic activity and methods for the use thereof
EP1222925A3 (en) Kavalactone as TNF-alpha production inhibitor

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 20040129

FG3A Patent granted, date of granting

Effective date: 20050804